altimmune glp-1 Obesity Drug Sheds Fat With Less Muscle Loss in Trial 🚨 ALTIMMUNE (ALT) — THE

Do not use this container for more than one patient

This is because, when the peptide vial is thawed, it can expose the contents to temperature changes and physical stress, which may affect stability over extended periods of time

Evidence-based off-label use: A doctor prescribes semaglutide for obesity-related complications even at a slightly lower BMI threshold than official labeling, based on published trial data and the patients overall risk profile

doi: 10.1210/jc.2011-3061 [DOI] [PubMed] [Google Scholar] 113

4 , 4927 (2014) Y

These benefits appear to come primarily through satiety and calorie displacement rather than hormonal manipulation